Industry Developments

BMI View: The new co-promotion deal is likely to be good news for all involved as it will boost Pfizer's presence in Africa, without exposing them to much risk, while Specpharm will... 2012-04-04

BMI View: Despite the strong disease burden, population demographics and macroeconomic factors that favour investment in the UAE's healthcare sector, BMI was not surprised that NMC... 2012-04-03

BMI View: Swaziland is a very small and risky market. Despite the government passing new legislation to better regulate the quality of pharmaceuticals, realistically Swaziland will... 2012-04-02

BMI View: Multinational drugmakers are becoming increasingly focused on supplying emerging markets to drive growth. This presents opportunities for freight and shipping companies to... 2012-03-29

BMI View: Multinational drugmakers are becoming increasingly focused on supplying emerging markets to drive growth. This presents opportunities for freight and shipping companies to... 2012-03-28

BMI View: The increasing international pressure on Iran, as the likelihood of a military strike by Israel increases and the country draws closer to obtaining nuclear capabilities, means... 2012-03-26

BMI View: We believe despite a temporary cash flow crisis for private hospitals in Jordan they will still have profited greatly from the influx of Libyan patients. It is our view that... 2012-03-22

BMI View: Although smoking is not as popular in the Middle East and North Africa (MENA) as it seems to be in Asia Pacific and Eastern Europe, it represents a considerable health risk,... 2012-03-21

BMI View: Increased investment in private healthcare infrastructure across the Gulf Cooperation Council (GCC) region will increase standards of care, making it a more appealing destination... 2012-03-20

BMI View: Continued improvement to Lebanon's intellectual property (IP) and pharmaceutical regulatory environment reinforces BMI's view that the country will begin to attract investment... 2012-03-15